These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2649987)
1. The role of ifosfamide in testicular cancer. Schmoll HJ Semin Oncol; 1989 Feb; 16(1 Suppl 3):82-95. PubMed ID: 2649987 [TBL] [Abstract][Full Text] [Related]
2. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
4. The role of ifosfamide in the treatment of testicular and urothelial malignancies. Roth BJ Semin Oncol; 1996 Jun; 23(3 Suppl 7):19-27. PubMed ID: 8711497 [TBL] [Abstract][Full Text] [Related]
5. Ifosfamide in the treatment of germ cell tumors. Nichols CR Semin Oncol; 1996 Jun; 23(3 Suppl 6):65-73. PubMed ID: 8677452 [TBL] [Abstract][Full Text] [Related]
6. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059 [TBL] [Abstract][Full Text] [Related]
7. [Results of chemotherapy and salvage surgery for advanced testicular cancer]. Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743 [TBL] [Abstract][Full Text] [Related]
8. Ifosfamide in testicular cancer: the Indiana University experience. Loehrer PJ; Williams SD; Einhorn LH Semin Oncol; 1989 Feb; 16(1 Suppl 3):96-101. PubMed ID: 2539649 [TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors. Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945 [TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C; J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869 [TBL] [Abstract][Full Text] [Related]
11. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162 [TBL] [Abstract][Full Text] [Related]
12. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related]
13. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor. Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O; Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861 [TBL] [Abstract][Full Text] [Related]
14. The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C; Harstrick A; Rüther U; Metzner B; Illiger HJ; Clemm C; Siegert W; Link H; Ostermann H; Schmoll HJ Semin Oncol; 1994 Dec; 21(6 Suppl 16):57-63. PubMed ID: 7801148 [TBL] [Abstract][Full Text] [Related]
15. Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors. Mardiak J; Fuchsberger P; Lakota J; Sálek T; Sycová-Milá Z; Drahokoupilová M; Baláz M; Koza I Neoplasma; 2000; 47(4):239-43. PubMed ID: 11043829 [TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521 [TBL] [Abstract][Full Text] [Related]